Diagnostic value of combined detection of soluble human leukocyte antigen-G, alpha fetoprotein and alpha fetoprotein-L3 in primary hepatocellular carcinoma

Clinical Focus ›› 2014, Vol. 29 ›› Issue (8): 888-890891.

Previous Articles Next Articles

Diagnostic value of combined detection of soluble human leukocyte antigen-G, alpha fetoprotein and alpha fetoprotein-L3 in primary hepatocellular carcinoma

YANG Shou-ping;LI Hai-ying;ZHANG Li

Online:2014-08-05 Published:2014-08-05

Abstract

CLC Number:

R735.7

YANG Shou-ping;LI Hai-ying;ZHANG Li. Diagnostic value of combined detection of soluble human leukocyte antigen-G, alpha fetoprotein and alpha fetoprotein-L3 in primary hepatocellular carcinoma[J]. Clinical Focus, 2014, 29(8): 888-890891.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/

https://huicui.hebmu.edu.cn/EN/Y2014/V29/I8/888

[1]	Li Ya, Du Taoming, Qiu Shixiang, Chen Chao, Zhong Liming. Study on brain functional connectivity in patients with liver cancer with depression [J]. Clinical Focus, 2023, 38(6): 532-536.
[2]	Li Ya, Qiu Shixiang, Chen Chao, Zhong Liming. Depression-related factors and corresponding correlations with quality of life in patients with hepatocellular carcinoma [J]. Clinical Focus, 2022, 37(6): 539-543.
[3]	Guo Xiaojun, Kong Yanliang, Liu Tao, Cheng Zhengxiang, Zhang Rui, Fan Lei. CT-guided percutaneous radiofrequency ablation for hepatic carcinoma [J]. Clinical Focus, 2021, 36(9): 807-810.
[4]	Xie Zhihai, Zhou Zhicong, Gui Yuan, Sun Jingfeng. Differential expression of IGF1R antisense noncoding RNA in hepatocellular carcinoma [J]. Clinical Focus, 2021, 36(7): 620-622.
[5]	Sun Tingting1, Guo Jian2a, Sun Wenwen2b, Zhao Yanzhen1, Liu Limin1, Zhu Bin1. Incidence of hepatocarcinoma in patients with chronic hepatitis combined with diabetes--a metaanalysis [J]. Clinical Focus, 2018, 33(6): 519-524,531.
[6]	Huang Jie1，2， Nie Fang1， Yang Liwen2， Li Jing1. Characteristics of type 2 diabetes mellitus patients with primary liver cancer by ultrasonographic and risk factor analysis [J]. Clinical Focus, 2017, 32(10): 873-876.
[7]	Liu Huimin,Liu Ping. Study on using ROC curve evaluation of α-L-fucosidase, 5'-nucleo tidase and alpha fetoprotein diagnostic and predictive value in hepatocellular carcinoma [J]. Clinical Focus, 2016, 31(4): 414-417.
[8]	Zhao Baohong，Xu Qian，Zeng Yanhong， Guo Zhojun，Lin Qiang， Zhang Yuhuan. Effect of GdDTPA to liver parenchyma and intrahepatic common malignant lesions on T2weighted imaging [J]. Clinical Focus, 2016, 31(11): 1244-1247.
[9]	Zheng Jianxiao;Wu Jinming. Effect of Fuzhengbuxu decotion on T cell subsets and angiogenesis related factors of patients with primary hepatic carcinoma [J]. Clinical Focus, 2015, 30(9): 1036-1038.
[10]	Zhang Zhiyong;Zhang Qian. Change and clinical significance of serum microRNA-106b expression in hepatocarcinoma patients after transcatheter hepatic arterial chemoembolization [J]. Clinical Focus, 2015, 30(12): 1390-1.39214e+007.
[11]	Gu Tao;Liu Lijie;Meng Wei;Hua Haixia;Zhang Yunjie;Zhang Qiuli. Level and significance of circulating histones in patients with hepatocellular carcinoma treated by radiofrequency ablation [J]. Clinical Focus, 2015, 30(12): 1386-1389.
[12]	YUAN Su-yun;LAN Tao;ZHOU Guo-qing;WANG Gui-hua;LI Zhi-juan. Effects of ubenimex capsules on serum levels of vascular endothelial growth factors in primary liver carcinoma [J]. CLINICAL FOCUS, 2014, 29(3): 318-320.

Diagnostic value of combined detection of soluble human leukocyte antigen-G, alpha fetoprotein and alpha fetoprotein-L3 in primary hepatocellular carcinoma

PDF (PC)

Knowledge

Cited

Abstract

Cite this article

share this article

References

Related Articles 12

Recommended Articles

Metrics

Comments